Barbara Lasut-Szyszka

Publikationer
Populärvetenskap och samverkan

Artiklar

Journal article: CANCERS. 2025;17(2):175
Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses
Drzyzga A; Czapla J; Matuszczak S; Łasut-Szyszka B; Cichoń T; Pilny E; Jarosz-Biej M; Smolarczyk R
Journal article: APOPTOSIS. 2024;29(9-10):1515-1528
Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand.
Łasut-Szyszka B; Gdowicz-Kłosok A; Krześniak M; Głowala-Kosińska M; Będzińska A; Rusin M
Journal article: BIOMEDICINES. 2024;12(7):1449
The Strong Activation of p53 Tumor Suppressor Drives the Synthesis of the Enigmatic Isoform of DUSP13 Protein.
Krześniak M; Łasut-Szyszka B; Będzińska A; Gdowicz-Kłosok A; Rusin M
Journal article: CHEMICO-BIOLOGICAL INTERACTIONS. 2024;392:110946
Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes.
Łasut-Szyszka B; Gdowicz-Kłosok A; Małachowska B; Krześniak M; Będzińska A; Gawin M; Pietrowska M; Rusin M
Journal article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(8):7645
The Wheel of p53 Helps to Drive the Immune System.
Łasut-Szyszka B; Rusin M
Journal article: PHARMACEUTICALS. 2022;15(5):631
Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade.
Piwowarczyk-Nowak A; Pałasz A; Suszka-Świtek A; Błaszczyk I; Bogus K; Łasut-Szyszka B; Krzystanek M; Worthington JJ
Journal article: CANCERS. 2022;14(7):1844
Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma.
Butkiewicz D; Gdowicz-Kłosok A; Krześniak M; Rutkowski T; Łasut-Szyszka B; Składowski K
Journal article: ACTA BIOCHIMICA POLONICA. 2022;69(1):205-210
Activation of the atypical NF-κB pathway induced by ionizing radiation is not affected by the p53 status.
Zając G; Rusin M; Łasut-Szyszka B; Puszyński K; Widłak P
Journal article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(20):11072
Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity.
Łasut-Szyszka B; Małachowska B; Gdowicz-Kłosok A; Krześniak M; Głowala-Kosińska M; Zajkowicz A; Rusin M
Journal article: CELLULAR SIGNALLING. 2020;69:109552
Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity.
Krześniak M; Zajkowicz A; Gdowicz-Kłosok A; Głowala-Kosińska M; Łasut-Szyszka B; Rusin M
Journal article: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2018;655:26-36
PIM2 survival kinase is upregulated in a p53-dependent manner in cells treated with camptothecin or co-treated with actinomycin D and nutlin-3a.
Zajkowicz A; Krześniak M; Gdowicz-Kłosok A; Łasut B; Rusin M
Journal article: CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2018;17(6):458-463
Long-term Treatment with Olanzapine Increases the Number of Sox2 and Doublecortin Expressing Cells in the Adult Subventricular Zone.
Lasut B; Palasz A; Filipczyk L; Arias-Carrion O; Rojczyk E; Savchyna M; Bogus K; Worthington JJ; Krzystanek M; Wiaderkiewicz R
Journal article: NEUROSCIENCE LETTERS. 2018;681:62-67
The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein.
Zajkowicz A; Gdowicz-Kłosok A; Krześniak M; Janus P; Łasut B; Rusin M
Journal article: BIOMEDICINE & PHARMACOTHERAPY. 2016;80:236-243
Methylglyoxal (MGO) inhibits proliferation and induces cell death of human glioblastoma multiforme T98G and U87MG cells.
Paul-Samojedny M; Łasut B; Pudełko A; Fila-Daniłow A; Kowalczyk M; Suchanek-Raif R; Zieliński M; Borkowska P; Kowalski J

Artiklar

Nyheter från KI

Kalenderhändelser från KI